Clinical trial

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Janssen Research & Development, LLCCompletedPhase 3Started Sep 30, 2015802 enrolledUnited States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Finland, France, Germany, Lithuania, Malaysia, Mexico, Poland, South Africa, South Korea, Spain, Sweden, Taiwan, Turkey (Türkiye), United KingdomNCT02497287

Abstract

The purpose of this open-label, multicenter study is to assess the long term safety and efficacy of intranasal esketamine plus an oral antidepressant in participants with treatment-resistant depression (TRD).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Treatment-resistant DepressionEsketamineOral AntidepressantTreatment-resistant Depression

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.